Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $50,000,021 |
Sells | 208 | $144,175,591 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 03 Jan 2024 | Sale | 10,300 | 19.03 | 196,009 | D |
12 Jun 2023 21:22 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 08 Jun 2023 | Sale | 14,189 | 13.47 | 191,126 | D |
11 Oct 2022 09:00 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 07 Oct 2022 | Sale | 14,200 | 13.37 | 189,854 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 02 Jan 2024 | Sale | 11,900 | 13.1 | 155,890 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 29 Feb 2024 | Sale | 5,520 | 27.5 | 151,800 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 03 Jan 2024 | Sale | 7,691 | 18.34 | 141,053 | D |
23 Jan 2023 08:27 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 18 Jan 2023 | Sale | 10,000 | 14.03 | 140,300 | D |
14 Feb 2024 16:27 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Feb 2024 | Sale | 5,493 | 25.07 | 137,710 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 5,580 | 23.98 | 133,808 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 5,580 | 23.98 | 133,808 | I |
15 Jun 2023 17:46 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 15 Jun 2023 | Sale | 10,000 | 12.03 | 120,300 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 29 Feb 2024 | Sale | 4,268 | 27.5 | 117,370 | D |
20 Sep 2023 16:47 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 18 Sep 2023 | Sale | 12,032 | 9.41 | 113,221 | D |
04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 5,361 | 20.5 | 109,900 | D |
15 Mar 2023 17:49 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 14 Mar 2023 | Sale | 7,441 | 13.33 | 99,189 | D |
15 Mar 2023 17:49 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 14 Mar 2023 | Sale | 7,318 | 13.33 | 97,549 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 3,821 | 24.68 | 94,302 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 3,821 | 24.68 | 94,302 | I |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 29 Feb 2024 | Sale | 3,429 | 27.5 | 94,298 | D |
11 Jun 2024 19:34 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Jun 2024 | Sale | 2,913 | 31.23 | 90,973 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 20 Feb 2024 | Sale | 3,510 | 23.4 | 82,134 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 20 Feb 2024 | Sale | 3,510 | 23.4 | 82,134 | I |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 11 Dec 2023 | Sale | 7,585 | 10.72 | 81,311 | D |
13 Sep 2023 19:50 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 12 Sep 2023 | Sale | 7,672 | 10.41 | 79,866 | D |
11 Jun 2024 19:34 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Jun 2024 | Sale | 2,357 | 31.23 | 73,609 | D |
02 Nov 2023 17:16 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 02 Nov 2023 | Sale | 9,939 | 7.4 | 73,549 | D |
11 Jun 2024 19:42 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Jun 2024 | Sale | 2,136 | 31.34 | 66,942 | D |
17 May 2024 21:03 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 16 May 2024 | Sale | 2,279 | 28.2 | 64,268 | D |
17 May 2024 21:05 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 16 May 2024 | Sale | 2,249 | 28.2 | 63,422 | D |
11 Mar 2024 21:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 07 Mar 2024 | Sale | 2,434 | 25.85 | 62,919 | D |
17 May 2024 21:07 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 16 May 2024 | Sale | 2,222 | 28.2 | 62,660 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | D |
11 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 07 Mar 2024 | Sale | 2,373 | 25.85 | 61,342 | D |
17 May 2024 21:04 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 16 May 2024 | Sale | 2,126 | 28.2 | 59,953 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Mar 2024 | Sale | 2,292 | 25.7 | 58,904 | D |
11 Mar 2024 21:45 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 07 Mar 2024 | Sale | 2,273 | 25.85 | 58,757 | D |
11 Jun 2024 19:34 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Jun 2024 | Sale | 1,823 | 31.34 | 57,133 | D |
17 May 2024 21:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 16 May 2024 | Sale | 1,956 | 28.2 | 55,159 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
12 Mar 2024 21:42 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Mar 2024 | Sale | 2,081 | 25.7 | 53,482 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | I |
12 Aug 2024 16:05 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director | 09 Aug 2024 | Sale | 1,160 | 44.04 | 51,086 | I |
11 Jun 2024 19:41 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Jun 2024 | Sale | 1,628 | 31.27 | 50,908 | D |
11 Jun 2024 19:28 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 10 Jun 2024 | Sale | 1,590 | 30.23 | 48,066 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Mar 2024 | Sale | 1,776 | 25.71 | 45,661 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 1,442 | 29.7 | 42,827 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 01 Mar 2024 | Sale | 1,414 | 29.7 | 41,996 | D |
11 Jun 2024 19:28 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Jun 2024 | Sale | 1,331 | 31.34 | 41,714 | D |
11 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 07 Mar 2024 | Sale | 1,591 | 25.85 | 41,127 | D |
11 Mar 2024 21:52 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 07 Mar 2024 | Sale | 1,557 | 26.2 | 40,793 | D |
12 Mar 2024 21:58 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Mar 2024 | Sale | 1,585 | 25.7 | 40,734 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Mar 2024 | Sale | 1,590 | 24.99 | 39,734 | D |
22 May 2024 21:01 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 20 May 2024 | Sale | 1,145 | 34.08 | 39,022 | D |
04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 04 Jan 2024 | Sale | 2,009 | 18.04 | 36,242 | D |
13 Dec 2022 17:04 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | See Remarks | 12 Dec 2022 | Sale | 3,322 | 10.87 | 36,110 | D |
11 Jun 2024 19:41 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Jun 2024 | Sale | 1,008 | 31.27 | 31,520 | D |
14 Dec 2023 16:59 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 14 Dec 2023 | Sale | 2,376 | 12.02 | 28,560 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Mar 2024 | Sale | 1,082 | 25.7 | 27,807 | D |
12 Mar 2024 21:58 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Mar 2024 | Sale | 1,030 | 25.58 | 26,347 | D |
20 Sep 2023 16:48 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 18 Sep 2023 | Sale | 2,672 | 9.41 | 25,144 | D |
06 Dec 2023 18:13 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 06 Dec 2023 | Sale | 1,872 | 12.01 | 22,483 | D |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 13 Jun 2023 | Sale | 1,698 | 12.43 | 21,106 | D |
15 Mar 2023 17:50 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 14 Mar 2023 | Sale | 1,559 | 13.33 | 20,781 | D |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 13 Jun 2023 | Sale | 1,625 | 12.43 | 20,199 | D |
15 Mar 2023 17:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 14 Mar 2023 | Sale | 1,416 | 13.33 | 18,875 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 689 | 27.31 | 18,817 | D |
14 Jun 2023 18:39 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 13 Jun 2023 | Sale | 1,475 | 12.43 | 18,334 | D |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Dec 2023 | Sale | 1,688 | 10.72 | 18,095 | D |
13 Sep 2023 19:56 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Sep 2023 | Sale | 1,707 | 10.41 | 17,770 | D |
15 Mar 2023 17:51 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 14 Mar 2023 | Sale | 1,311 | 13.33 | 17,476 | D |
12 Dec 2023 17:34 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Dec 2023 | Sale | 1,616 | 10.72 | 17,324 | D |
15 Jun 2023 17:46 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 13 Jun 2023 | Sale | 1,390 | 12.43 | 17,278 | D |
13 Sep 2023 19:51 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 12 Sep 2023 | Sale | 1,635 | 10.41 | 17,020 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 01 Mar 2024 | Sale | 564 | 28.65 | 16,159 | D |
15 Mar 2023 17:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 14 Mar 2023 | Sale | 1,209 | 13.33 | 16,116 | D |
12 Dec 2023 17:32 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Dec 2023 | Sale | 1,467 | 10.72 | 15,726 | D |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 13 Jun 2023 | Sale | 1,259 | 12.43 | 15,649 | D |
13 Sep 2023 19:50 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 12 Sep 2023 | Sale | 1,484 | 10.41 | 15,448 | D |
12 Dec 2023 17:35 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 11 Dec 2023 | Sale | 1,380 | 10.72 | 14,794 | D |
13 Sep 2023 19:53 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 12 Sep 2023 | Sale | 1,397 | 10.41 | 14,543 | D |
17 May 2024 21:03 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 16 May 2024 | Sale | 495 | 28.59 | 14,152 | D |
17 May 2024 21:05 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 16 May 2024 | Sale | 489 | 28.59 | 13,981 | D |
17 May 2024 21:07 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 16 May 2024 | Sale | 483 | 28.59 | 13,809 | D |
20 Sep 2023 16:47 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 18 Sep 2023 | Sale | 1,436 | 9.41 | 13,513 | D |
12 Dec 2023 17:34 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Dec 2023 | Sale | 1,245 | 10.72 | 13,346 | D |
17 May 2024 21:04 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 16 May 2024 | Sale | 462 | 28.59 | 13,209 | D |
13 Sep 2023 19:53 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 12 Sep 2023 | Sale | 1,266 | 10.41 | 13,179 | D |
15 Mar 2023 17:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 13 Mar 2023 | Sale | 1,000 | 13 | 13,000 | D |
14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 12 Jun 2023 | Sale | 1,000 | 13 | 13,000 | D |
17 May 2024 21:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 16 May 2024 | Sale | 425 | 28.59 | 12,151 | D |
20 Sep 2023 16:49 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | See Remarks | 18 Sep 2023 | Sale | 1,290 | 9.41 | 12,139 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 435 | 27.38 | 11,910 | D |
20 Sep 2023 16:49 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 18 Sep 2023 | Sale | 1,261 | 9.41 | 11,866 | D |
12 Dec 2023 17:33 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Dec 2023 | Sale | 978 | 10.55 | 10,318 | D |
28 Feb 2024 17:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 28 Feb 2024 | Sale | 407 | 25 | 10,175 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)